These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1568412)

  • 81. Fibrin related antigen: an aid in cytologically false negative effusion fluid.
    Crandon AJ; Singh P
    Asia Oceania J Obstet Gynaecol; 1984 Mar; 10(1):101-4. PubMed ID: 6732619
    [No Abstract]   [Full Text] [Related]  

  • 82. Immunohistochemistry in tumour diagnosis.
    Miettinen M
    Ann Med; 1993 Jun; 25(3):221-33. PubMed ID: 8333922
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Use of selected combinations of monoclonal antibodies to tumor associated antigens in the diagnosis of neoplastic effusions of unknown origin.
    Mottolese M; Venturo I; Donnorso RP; Curcio CG; Rinaldi M; Natali PG
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1277-84. PubMed ID: 3053205
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.
    Ghosh AK; Mason DY; Spriggs AI
    J Clin Pathol; 1983 Oct; 36(10):1150-3. PubMed ID: 6194182
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Immunocytological analysis of the Tn associated antigen 83D4 in serous effusions from patients with cancer: comparison with Tn soluble glycoprotein.
    Beuzelin-Yvraut M; Bourguignat A; Phillips E; Roseto A; Osinaga E
    J Clin Pathol; 1995 May; 48(5):433-7. PubMed ID: 7629290
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen.
    Mezger J; Stötzer O; Schilli G; Bauer S; Wilmanns W
    Acta Cytol; 1992; 36(1):75-81. PubMed ID: 1546516
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Selected monoclonal antibodies can increase the accuracy of cytodiagnosis of neoplastic effusions of cryptic origin expanded in a short term culture.
    Mottolese M; Cianciulli A; Venturo I; Perrone Donnorso R; Salzano M; Benevolo M; Bigotti G; Natali PG
    Diagn Cytopathol; 1992; 8(2):153-60. PubMed ID: 1568412
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Comparative study of the expression of CEA and a myelomonocytic antigen (CD15) in serous effusions using two monoclonal antibodies NEO 723 and Leu M1].
    Daste G; Berthier F; Mauduyt MA; Soleilhavoup JP
    Arch Anat Cytol Pathol; 1992; 40(4):183-9. PubMed ID: 1294046
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Ovarian carcinoma and serous effusions. Changing views regarding tumor progression and review of current literature.
    Davidson B
    Anal Cell Pathol; 2001; 23(3-4):107-28. PubMed ID: 12082292
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Malignant effusions: from diagnosis to biology.
    Davidson B
    Diagn Cytopathol; 2004 Oct; 31(4):246-54. PubMed ID: 15452897
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Tumor microenvironment: what can effusions teach us?
    Kassis J; Klominek J; Kohn EC
    Diagn Cytopathol; 2005 Nov; 33(5):316-9. PubMed ID: 16240401
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Use of immunologic tumor markers in body fluid analysis.
    Kjeldsberg CR; Marty J
    Clin Lab Med; 1985 Jun; 5(2):233-64. PubMed ID: 3896624
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Minimally Invasive, Maximally Effective: The Power of Precision Cytoanalysis on Effusion Samples-A Comprehensive Exploration from Traditional Methods to Innovative Approaches.
    Souza da Silva R; Schmitt F
    Surg Pathol Clin; 2024 Sep; 17(3):453-481. PubMed ID: 39129143
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.